The industry of stem cell therapy is experiencing rapid expansion, attracting both significant investment and intense public attention. This multifaceted financial landscape is defined by a spectrum of factors, including governmental frameworks, clinical trial costs, and the evolving demands of the

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These techniques involve small incisions and minimal tissue ma